메뉴 건너뛰기




Volumn 26, Issue 4, 2002, Pages 504-509

The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects

Author keywords

C reactive protein; Chronic systemic inflammation; Leptin; Obesity; PEG OB; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; LONG ACTING DRUG; PEGYLATED RECOMBINANT HUMAN LEPTIN; PLACEBO; RECOMBINANT LEPTIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

EID: 85047696643     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801952     Document Type: Article
Times cited : (97)

References (26)
  • 15
    • 0033304576 scopus 로고    scopus 로고
    • Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 3686-3695
    • Ozata, M.1    Ozdemir, I.C.2    Licinio, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.